Mesoglycan

Drug Profile

Mesoglycan

Alternative Names: Mediolanum; MF 090; Perclar; Prisma

Latest Information Update: 21 Jun 2000

Price : $50

At a glance

  • Originator Mediolanum
  • Developer Medinfar; Mediolanum; Pfizer
  • Class Antithrombotics; Glycosaminoglycans; Vascular disorder therapies
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Peripheral vascular disorders

Most Recent Events

  • 21 Jun 2000 Warner-Lambert has merged with Pfizer
  • 23 Jul 1999 Launched for Peripheral vascular disorders in Italy (Unknown route)
  • 23 Jul 1999 Launched for Peripheral vascular disorders in Portugal (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top